TMPRSS2 Inhibitor Discovery Facilitated through an In Silico and Biochemical Screening Platform
Description
The COVID-19 pandemic has highlighted the need for new antiviral approaches because many of the currently approved drugs have proven ineffective against mitigating SARS-CoV-2 infections. The host transmembrane serine protease TMPRSS2 is a promising